WHO ICTRP trial
Multi center, open, single arm, single dose increasing phase I/IIa clinical…
ChiCTR2200066399 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200066399 |
|---|---|
| Public title | Multi center, open, single arm, single dose increasing phase I/IIa clinical trial to evaluate the safety, tolerance and initial efficacy of GC101 adeno-associated virus injection in the treatment of type 1 SMA patients |
| Scientific title | Multi center, open, single arm, single dose increasing phase I/IIa clinical trial to evaluate the safety, tolerance and initial efficacy of GC101 adeno-associated virus injection in the treatment of type 1 SMA patients |
| Primary sponsor | The seventh medical center of PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1-2 |
| Countries | China |
| Conditions | type 1 spinal muscular atrophy |
| Interventions | treatment group:GC101 intrathecal injection |
| Registration date | Dec 5, 2022 |
| Target size | treatment group:15 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: